Sharon Rosenzweig-Lipson

Sharon Rosenzweig-Lipson

Company: AgeneBio

Job title: Vice President of Research & Development


How to Define Patient Selection, Selection of Optimal Intervention Points & Therapeutic Outcomes Using Biomarkers & “Prodromal AD” 11:20 am

Learning tips and tricks to streamline the use of “biomarkers” for patient selection Using longitudinal biomarker measures of high scientific interest in the field to augment the use of ‘clinical/cognitive efficacy” outcomes Uncovering data driven methods to optimize the selection of patient and protocol duration and endpointsRead more

stream: Stream one
day: Track B - Day 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.